Han, H. S., Aldrich, A., Whiting, J., Soliman, H. H., Costa, R. L., Armaghani, A. J., Muller, A. E. S., O'Connor, T. L., Loftus, L. S., Dvir, K., Abdo, N., Lee, M. C., Khakpour, N., Kruper, L., Kiluk, J., Hendel, R., Mo, Q., Weinfurtner, R. J., Jameel, Z., Czerniecki, B. J. (2026). Intratumoral dendritic cell (DC1) therapy prior to neoadjuvant chemotherapy in HER2-positive breast cancer (NATASHA trial).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2594